HHS Announces Availability of $100 Million for State Loan Repayment Programs to Support Primary Health Care Workforce in Underserved CommunitiesOctober 14, 2021
FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback’s EUA Application for COVID-19 Oral TreatmentOctober 14, 2021
FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease TreatmentsOctober 14, 2021
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan ImpurityOctober 14, 2021
Declaraciones del Secretario de Salud y Servicios Humanos Xavier Becerra sobre la guía para la reducción de sodio de la FDAOctober 13, 2021
To Improve Nutrition and Reduce the Burden of Disease, FDA Issues Food Industry Guidance for Voluntarily Reducing Sodium in Processed and Packaged FoodsOctober 13, 2021
Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super PotencyOctober 12, 2021
FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the AgencyOctober 12, 2021
Tuffy’s Pet Foods; Inc. Issues Voluntary Recall of a Limited Quantity of Pure Vita Salmon Entrée Dog Food in a Tetrapak Carton Due to Potentially Elevated Levels of Vitamin DOctober 12, 2021
Biden-Harris Administration Greenlights Coverage of LGBTQ+ Care as an Essential Health Benefit in ColoradoOctober 12, 2021
